StockData
Elevance Health, Inc. logo

Elevance Health, Inc. (ELV) operating KPIs

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$420.07−1.95 (-0.46%)

Close on Oct 30, 2026Market cap $91.10BP/E 18.7Yield –

Elevance Health diluted Weighted-Average Common Shares (M)

Quarterly figures from Elevance Health's filings and investor materials

QuarterlyAnnual
Latest, Q3 2026
218
Period ended Sep 30, 2026
Change on a year earlier
-2.7%
224 in Q3 2025
History
47 quarters
Since Q1 2015
Sources
3
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedDiluted Weighted-Average Common Shares (M)Year on yearSource
Q3 2026Sep 30, 2026218-2.7%ELV 10-Q (XBRL us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding) ↗
Q2 2026Jun 30, 2026218-3.5%ELV 10-Q (XBRL us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding) ↗
Q1 2026Mar 31, 2026220-3.0%ELV 10-Q (XBRL us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding) ↗
Q4 2025Dec 31, 2025-1+42.9%ELV 10-K (XBRL us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding) ↗
Q3 2025Sep 30, 2025224-4.0%ELV 10-Q (XBRL us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding) ↗
Q2 2025Jun 30, 2025226-3.3%ELV 10-Q (XBRL us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding) ↗
Q1 2025Mar 31, 2025227-3.0%ELV 10-Q (XBRL us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding) ↗
Q4 2024Dec 31, 2024-0.70+16.7%ELV 10-K (XBRL us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding) ↗
Q3 2024Sep 30, 2024233-1.4%ELV 10-Q (XBRL us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding) ↗
Q2 2024Jun 30, 2024233-1.9%ELV 10-Q (XBRL us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding) ↗
Q1 2024Mar 31, 2024234-2.3%ELV 10-Q (XBRL us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding) ↗
Q4 2023Dec 31, 2023-0.60+20.0%ELV 10-K (XBRL us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding) ↗
Q3 2023Sep 30, 2023237-2.4%ELV 10-Q (XBRL us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding) ↗
Q2 2023Jun 30, 2023238-2.3%ELV 10-Q (XBRL us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding) ↗
Q1 2023Mar 31, 2023240-1.9%ELV 10-Q (XBRL us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding) ↗
Q4 2022Dec 31, 2022-0.50+25.0%ELV 10-K (XBRL us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding) ↗

Cite this data

StockData. (2026). Elevance Health Diluted Weighted-Average Common Shares (M), quarterly Q1 2015–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/fin_shares_diluted

See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.